870194-63-1Relevant articles and documents
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists: Part 1
Epple, Robert,Russo, Ross,Azimioara, Mihai,Cow, Christopher,Xie, Yongping,Wang, Xing,Wityak, John,Karanewsky, Don,Gerken, Andrea,Iskandar, Maya,Saez, Enrique,Martin Seidel,Tian, Shin-Shay
, p. 4376 - 4380 (2007/10/03)
We report the identification of a novel series of trisubstituted isoxazoles as PPAR activators from a high-throughput screen. A series of structural optimizations led to improved efficacy and excellent functional receptor selectivity for PPARδ. The isoxazoles represent a series of agonists which display a scaffold that lies outside the typical PPAR agonist motif.
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
-
, (2010/02/14)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR .